Richard Kenny combines deep technical training in enzyme bioengineering from Oxford with hands-on operating experience scaling AlgaPrime DHA at Solazyme, giving him rare first-hand knowledge of commercializing industrial biotech products rather than just investing from the sidelines. He operates in a dual role as both founder of Hawkwood Biotech Partners and Venture Partner at Genoa Ventures, allowing portfolio companies to engage with him as both an investor and a hands-on scaling partner who systematically applies lessons from past industrial biotech cycles.